Mathew Anna G, Kaye Alexander J, Patel Shivani J, Meyers Sarah R, Saiganesh Pooja, Wang Weizheng
Internal Medicine, Rutgers University New Jersey Medical School, Newark, USA.
Psychiatry, Rutgers Robert Wood Johnson Medical School, Piscataway, USA.
Cureus. 2023 Mar 6;15(3):e35832. doi: 10.7759/cureus.35832. eCollection 2023 Mar.
Background Gastroparesis is a common gastrointestinal pathology that has been increasing in prevalence and represents a significant cost to the United States healthcare system. Gastroparesis is associated with psychological dysfunction, including generalized anxiety disorder (GAD). GAD is known to be a prevalent and chronic manifestation of anxiety, which has been increasing in prevalence since the year 2020. Despite the association between gastroparesis and GAD, there has been limited research on the possible impact GAD may have on the morbidity and mortality of patients hospitalized for gastroparesis, which is further evaluated in this study. Methods Using the Nationwide Inpatient Sample from the year 2014, a retrospective study was conducted to assess the outcomes of hospitalized gastroparesis patients with and without a history of GAD. In this study, the analyzed outcomes included acute kidney injury (AKI), acute respiratory failure, sepsis, acute deep vein thrombosis, myocardial infarction, intestinal obstruction, and inpatient mortality. To assess whether GAD is an independent risk factor for the outcomes, a multivariate logistic regression analysis was used. Results There were 22,150 patients with gastroparesis assessed in this study; GAD was found to be a comorbid diagnosis in 4,196 of those patients. In the GAD cohort, there was an elevated risk for AKI (adjusted odds ratio 1.24, p < 0.001). The adjusted odds ratios for acute respiratory failure, sepsis, acute deep vein thrombosis, myocardial infarction, intestinal obstruction, and inpatient mortality did not meet the threshold for statistical significance. Conclusion In hospitalized gastroparesis patients, GAD is a risk factor for AKI. This finding may be attributed to prerenal azotemia due to an increased risk of nausea and vomiting associated with GAD, as well as the medications used to treat GAD such as escitalopram and duloxetine. In addition, the dual inflammatory states caused by the co-existence of both GAD and gastroparesis may also have a role in increasing the risk for AKI. The results of this study may become increasingly relevant given the increasing prevalence of GAD. .
背景
胃轻瘫是一种常见的胃肠道疾病,其患病率一直在上升,给美国医疗系统带来了巨大成本。胃轻瘫与心理功能障碍有关,包括广泛性焦虑症(GAD)。GAD是一种常见的慢性焦虑表现,自2020年以来患病率一直在上升。尽管胃轻瘫与GAD之间存在关联,但关于GAD可能对因胃轻瘫住院患者的发病率和死亡率产生的影响的研究有限,本研究对此进行了进一步评估。
方法
利用2014年的全国住院患者样本进行了一项回顾性研究,以评估有和没有GAD病史的胃轻瘫住院患者的结局。在本研究中,分析的结局包括急性肾损伤(AKI)、急性呼吸衰竭、败血症、急性深静脉血栓形成、心肌梗死、肠梗阻和住院死亡率。为了评估GAD是否是这些结局的独立危险因素,使用了多因素逻辑回归分析。
结果
本研究共评估了22150例胃轻瘫患者;其中4196例患者被诊断为合并GAD。在GAD队列中,AKI风险升高(调整后的优势比为1.24,p<0.001)。急性呼吸衰竭、败血症、急性深静脉血栓形成、心肌梗死、肠梗阻和住院死亡率的调整后优势比未达到统计学意义阈值。
结论
在胃轻瘫住院患者中,GAD是AKI的一个危险因素。这一发现可能归因于与GAD相关的恶心和呕吐风险增加导致的肾前性氮质血症,以及用于治疗GAD的药物,如艾司西酞普兰和度洛西汀。此外,GAD和胃轻瘫并存所导致的双重炎症状态也可能在增加AKI风险方面起作用。鉴于GAD患病率的上升,本研究结果可能会变得越来越重要。